Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1НЦПЗ РАМН, Москва; 2ММА им. И.М.Сеченова
Список исп. литературыСкрыть список 1. Артемьева М.С., Сулейманов Р.А., Тихонравова Ю.Б. Характеристика разновидности синдрома дисморфофобии – дисморфомании с убежденностью в уродстве собственного голоса. Журн. неврол. и психиат. 2007; 107 (8): 66–9. 2. Березанцев А.Ю. Теоретические и клинические аспекты соматоформных расстройств и психосоматики. Рос. психиат. журн. 2001; 6: 4–8. 3. Выборных Д.Э. Нозогенные паранойяльные реакции (клиника, эпидемиология, терапия). Дис. … канд. мед. наук. М., 2000. 4. Дороженок И.Ю. Современные аспекты психофармакотерапии психодерматологических расстройств. Психиат. и психофармакотер. 2004; 6: 274–6. 5. Дороженок И.Ю., Львов А.Н., Терентьева М.А. Рисперидон при терапии патомимии в клинике психодерматологии. Психиат. и психофармакотер. 2003; 6: 236–7. 6. Каламкарян А.А., Брюн Е.А., Гребенюк В.Н. Кожный зуд, протекающий по типу тактильного галлюциноза. Вестн. дерматол. и венерол. 1978; 8: 90–2. 7. Концевой В.А. Функциональные психозы позднего возраста. Руководство по психиатрии по ред. А.С.Тиганова. М., 1999; том 1: 667–721. 8. Коркина М.В. Дисморфомания в подростковом и юношеском возрасте. М., 1984. 9. Львов А.Н. Дерматозы, коморбидные с психическими расстройствами: классификация, клиника, терапия и профилактика: Автореф. дис. … докт. мед. наук. М., 2006. 10. Морозов П.В. Юношеская шизофрения с дисморфофобическими расстройствами. Дис. … канд. мед. наук. М., 1977. 11. Николаев Ю.С. О сенситивном бреде физического недостатка и его нозологической принадлежности. Дис. … канд. мед. наук. М., 1945. 12. Николаев Ю.С. О своеобразном бредовом синдроме физического недостатка. Тр. Психиатрической клиники І Мед. ин-та № 9. 1949; с. 150–60. 13. Смулевич А.Б., Концевой В.А., Фролова В.И. и др. Малопрогредиентная шизофрения, протекающая с явлениями дерматозойного бреда. Психиатрия. 2005; 4: 12–9. 14. Смулевич А.Б., Концевой В.А., Дороженок И.Ю. и др. Дерматозойный (зоопатический) бред. Психиат. и психофармакотер. 2004; 6 (6): 267–70. 15. Смулевич А.Б., Иванов О.Л., Львов А.Н., Дороженок И.Ю. Психодерматология: современное состояние проблемы. Журн. неврол. и психиат. 2004; 11: 4–14. 16. Смулевич А.Б. Малопрогредиентная шизофрения и пограничные состояния. М., 1987. 17. Смулевич А.Б., Щирина М.Г. Проблема паранойи. М., 1972. 18. Фролова В.И. Коэнестезиопатическая паранойя (клинические и терапевтические аспекты дерматозойного бреда). Дис. … канд. мед. наук. М., 2006. 19. Штернберг Э.Я. Особые формы психозов позднего возраста. В кн.: Руководство по психиатрии. Под ред. А.С.Тиганова. М., 1999; с. 117–28. 20. AХt-Ameur A, Bern P, Firolini MP, Menecier P. Le d?lire de parasitose ou syndrome d\'Ekbom. Rev Med Interne 2000; 21: 182–6. 21. Aleman A, Larњi F. Hallucinations. The Science of Idiosyncratic Percepcion. American Psychological Association Washington, DC. 2008. 22. Andrews E, Bellard J, Walter-Ryan W. Monsymptomatic hypochondriacal psychosis manifesting as delusions of infestation: case studies of treatment with haloperidol. J Clin Psychiat 1986; 47: 188–90. 23. Berrios GE. Delusional parasitosis and physical disease. Compr Psychiat 1985; 26: 395–423. 24. Bhatia MS, Jagawat T, Choudhary S. Delusional parasitosis: a clinical profile. Int J Psychiat Med 2000; 30: 83–91. 25. Biby EL. The relationship between body dysmorphic disorder and depression, self-esteem, somatization, and obsessivecompulsive disorder. J Clin Psychol 1998; 54 (4): 489–99. 26. Bienvenu OJ, Samuels JF, Riddle MA et al. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiat 2000; 48: 287–93. 27. Bogren M, Mattisson C, Isberg PE, Nettelbladt P. How common are psychotic and bipolar disorders? A 50-year follow-up of the Lundby population. Nord J Psychiat 2009; 2: 1–11. 28. Bohne A, Wilhelm S, Keuthen NJ et al. Prevalence of body dysmorphic disorder in a German college student sample. Psychiat Res 2002; 109: 101–4. 29. Bohne A, Keuthen NJ, Wilhelm S, Deckersbach T. Prevalence of Symptoms of Body Dysmorphic Disorder and Its Correlates: A Cross-Cultural Comparison Psychosomatics 2002; 43: 486–90. 30. Bowe WP, Leyden JJ, Crerand CE et al. Body dysmorphic disorder symptoms among patients with acne vulgaris. J Am Acad Dermatol 2007; 57 (2): 222–30. 31. Bumke O. Lehbuch der Geisteskrankheiten. Munchen, 1924. – Berlin – Gottingen – Heidelberg, 1948. 32. Cansever A, Uzun O, DЪnmez E, Ozsahin A. The prevalence and clinical features of body dysmorphic disorder in college students: a study in a Turkish sample. Compr Psychiat 2003; 44 (1): 60–4. 33. Colombo G, Caimi M, Dona G. Shared Ekbom’s syndrome. A case study. Eur Psychiat 2003; 19: 115–6. 34. De Leon J, Antelo R, Simpson G. Delusion of parasitosis or chronic tactile hallucinoses: hypothesis about their brain physiopathology. Comp Psychiat 1992; 33: 25–33. 35. Damiani J, Flowers F, Pierce D. Pimozoide in delusions of parasitosis. J Amer Acad Dermatol 1990; 22: 212–3. 36. Ehsani AH, Toosi S, Mirshams Shahshahani M et al. Psycho-cutaneous disorders: an epidemiologic study. JEADV 2009; 23: 945–7. 37. Faravelli C, Salvatori S, Galassi F et al. Epidemiology of somatoform disorders: a community survey in Florence. Social Psychiatry and Psychiat Epidemiol 1997; 32: 24–9. 38. Fatemi SH, Clayton PJ. The Medical Basis of Psychiatry. 3d ed. 2008. 39. Fontenelle LF, Telles LL, Nazar BP et al. A sociodemographic, phenomenological, and long-term follow-up study of patients with body dysmorphic disorder in Brazil. Internat J Psychiat Med 2006; 36 (2): 243–59. 40. Freudenmann R. Der «Dermatozoenwahn». Eine aktuelle Жbersicht. Fortschr Neurol Psychiat 2002; 70: 531–41. 41. Freudenmann RW, Lepping P. Delusional Infestation. Clin Microbiol Rew 2009; 10: 690–732. 42. Gallucci G, Beard G. Risperidone and the treatment of delusions of parasitosis in an elderly patient. Psychosomatics 1995; 36: 578–80. 43. Garcia AC, Pinilla MM, HervЗs DC et al. Complications of dysmorphophobis. Description of a self-mutilation case. Actas Esp Psiquiatr 2006; 34 (3): 2002–5. 44. Gieler U, In Harth W, Gieler U et al. Clinical management in psychodermatology. Berlin – Heidelberg, 2009; p. 30–8. 45. Hamann K, Avnstorp C. Delusions of infestation treated by pimozide: a double-blind crossover clinical study. Acta Dermato-Venereol 1982; 62: 55–8. 46. Hanumantha K, Pradhan P, Suvarna B. Delusional parasitosis--study of 3 cases. J Postgrad Med 1994; 40 (4): 405–11. 47. Harth W, Gieler U, Kusnir D et al. Clnical Management in Psychodermatology. Springer-Verlag. Berlin Heidelbtrg. 48. Hebbar S, Ahuja N, Chandrasekaran R. High prevalence of delusional parasitosis in Indian setting. Ind J Psych 1999; 41 (2): 136–9. 49. Heim M, Morgner J. Chronic tactile hallucinations [in German]. Psychiatr Neurol Med Psychol (Leipz) 1980; 32: 405–11. 50. Hillert A, Gieler U, Niemer V, Brosig B. Delusional Parasitosis. Dermatol Psychosom 2004; 5: 33–5. 51. Hollander E, Allen A, Kwon J et al. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiat 1999; 56: 1033–9. 52. Hollander E, Cohen L, Simeon D et al. Fluvoxamine treatment of body dysmorphic disorder. J Clin Psychopharmacol 1994; 14: 75–7. 53. Hollander E, Liebowitz MR, Winchel R et al. Treatment of body-dysmorphic disorder with serotonin reuptake blockers. Am J Psychiat 1989; 146: 768–70. 54. Honigman R, Castle DJ. Living with your looks. Crawley: University of Western Australia Press, 2007. 55. Hsu C, Ali Juma H, Goh CL. Prevalence of Body Dysmorphic Features in Patients Undergoing Cosmetic Procedures at the National Skin Centre, Singapore. Dermatology. 2009 Jul 8. 56. Hwu HG, Yeh EK, Chang LY. Prevalence of psychiatric disorders in Taiwan defined by the Chinese diagnostic interview schedule. Acta Psychiat Scand 1989; 79: 136–47. 57. Ishigooka J, Iwao M, Suzuki M et al. Demographic features of patients seeking cosmetic surgery. Psychiat Clin Neurosci 1998; 52 (3): 283–7. 58. Jahrreiss JW. Die Schonheitshypochondrie. Arch F Psichiat Nervenkr 1930; 92: 686. 59. Kendler KS. Demography of paranoid psychosis (delusional disorder): a review and comparison with schizophrenia and affective illness. Arch Gen Psychiat 1982; 39 (8): 890–902. 60. Kim C, Kim J, Lee M. Delusional Parasitosis as «Folia-a-deux».J Korean Med Sci 2003; 18: 462–5. 61. Kleist К. Die Streitfrage der akuten Paranoia. Z Ges Neurol Psychiat 1911; 5: 366–87. 62. Koo J, Gambla C. Delusions of parasitosis and other forms of monosymptomatic hypochondriacal psychosis. General discussion and case illustrations. Dermatol Clin 1996; 14: 429–38. 63. Koo J, Lee C. Delusions of parasitosis. A dermatologist’s guide to diagnosis and treatment. Am J Clin Dermatol 2001; 5: 285–90. 64. Koran LM, Abujaoude E, Large MD, Serpe RT. The prevalence of body dysmorphic disorder in the United States adult population. CNS Spectr 2008; 13 (4): 316–22. 65. Kraepelin E. Manic-Depressive Insanity and Paranoia. Edinburgh, 1921; p. 280. 66. Ladee G. Hypochondriacal Syndromes. Amsterdam–London–New York, 1966. 67. Le L, Gonski PN. Delusional parasitosis mimicking cutaneous infestation in elderly patients. MJA 2003; 179 (4): 209–10. 68. Lepping P, Russel I, Freudenmann RW. Antipsychotic treatment of primary delusional parasitosis. Systematic review. Britsh J Psychiat 2007; 191: 198–205. 69. Lyell A. Delusions of parasitosis. Br J Dermatol 1983; 108: 485–99. 70. Magnan V, Saury M. Trois cas de cocainisme chronique. Comptes rendus des seances de la Societe de Biologie. 1889; p. 60–3. 71. Macaskill N. Delusional Parasitosis: Successful Non-pharmacological treatment of a Folia-a-deux. Br J Psychiat 1987; 150: 261–3. 72. Mayville S, Katz RC, Gipson MT, Cabral K. Assessing the prevalence of body dysmorphic disorder in an ethnically diverse group of adolescents. J Child Fam Stud 1999; 8: 357–62. 73. Marneros A, Deister A, Rohde A. Delusional parasitosis. A comparative study to late-onset schizophrenia and organic mental disorders due to cerebral arteriosclerosis. Psychopathology 1988; 21 (6): 267–74. 74. Meehan W, Badreshia S, Mackley C. Successful treatment of delusions of parasitosis with olanzapine. Arch Dermatol 2006; 142: 352–5. 75. Munro A. Monosymptomatic hypochondriacal psychoses: a diagnostic entity which may respond to pimozide. Can Psychiatr Assoc J 1978; 23 (7): 497–500. 76. Munro A. Monosymptomatic hypochondriacal psychosis manifesting as delusions of parasitosis. A description of four cases successfuly treated with pimozide. Archiv Dermatol 1978; 114: 940–3. 77. Munro A. Delusional disorder. Cambridge University Press, 1999. 78. Musalek M, Bach M, Passweg V, Jaeger S. The position of delusional parasitosis in psychiatric nosology and classification. Psychopathol 1990; 23: 115–24. 79. Musalek M. Wahnsyndrome in der Dermatologie. In Seelische Faktoren bei Hautkrankheiten Betrage zur Psychosomatischen Dermatologie. Verlag Hans Huber. Bern: 1996; s. 91–104. 80. Neziroglu F, Khemiani-Patel S. A review of cognitive and behavioral treatment for body dysmorphic disorder. CNS Spectrums 2002; 7: 464–71. 81. Otto MW, Wilhelm S, Cohen LS, Harlow BL. Prevalence of body dysmorphic disorder in a community. sample of women. Am J Psychiat 2001; 158: 2061–3. 82. Pavan C, Simonato P, Marini M et al. Psychopathologic aspects of body dysmorphic disorder; a literature review. Aesthetic Plast Surg 2008; 32 (3): 473–84. 83. Perala J, Suvisaari J, Saarni SI et al. Lifetime prevalence of psychotic and bipolar disorder in a general population. Arch Gen Psychiat 2007; 64: 19–28. 84. Perugi G, Giannotti D, Di Vaio S et al. Fluvoxamine in the treatment of body dysmorphic disorder (dysmorphophobia). Int Clin Psychopharmacol 1996; 11: 247–54. 85. Phillips KA, Menard W, Fay C. Gender similarities and differences in 200 individuals with body dysmorphic disorder. Compr Psychiat 2006; 47 (2): 77–87. 86. Phillips KA, Menard W, Pagano ME et al. Delusional versus nondelusional body dysmorphic disorder: Clinical features and course of illness. J Psychiat Res 2006; 40 (2): 95–104. 87. Phillips KA, Najar F. An open-label study of citalopram in body dysmorphic disorder. J Clin Psychiat 2003; 64: 715–20–38, 39. 88. Phillips KA. Pharmacologic treatment of body dysmorphic disorder: review of the evidence and a recommended treatment approach. CNS Spectrums 2002; 7: 453–60. 89. Phillips KA, Albertini RS, Rasmussen SA. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiat 2002; 59: 381–8. 90. Phillips KA, Albertini RS, Siniscalchi JM et al. Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study. J Clin Psychiat 2001; 62: 721–7. 91. Phillips KA, Castle DJ. Body dysmorphic disorder in men. BMJ 2001; 323: 1015–6. 92. Phillips KA, Dufresne RG. Body dysmorphic disorder. A guide for dermatologists and cosmetic surgeons. Am J Clin Dermatol 2000; 1 (4): 235–43. Rev. 93. Phillips KA. Body dysmorphic disorder: clinical aspects and treatment strategies. Bull Menninger Clin 1998; 62 (4 Suppl. A): A33–48. Rev. 94. Phillips KA, Dwight MM, McElroy SL. Efficacy and safety of fluvoxamine in body dysmorphic disorder. J Clin Psychiat 1998; 59: 165–71. 95. Phillips KA, Diaz SF. Gender differences in body dysmorphic disorder. J Nerv Mental Dis 1997; 185: 570–7. 96. Phillips KA, McElroy SL, Keck PEJr et al. A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull 1994; 30: 179–86. 97. Phillips KA, McElroy SL, Keck PEJr et al. Body dysmorphic disorder: 30 cases of imagined ugliness. Am J Psychiat 1993; 150: 302–8. 98. Proctor SE, Mitford E, Paxton R. First episode psychosis: a novel methodology reveals higher than expected incidence; a reality-based population profile in Northumberland, UK. J Eval Clin Pract 2004; 10 (4): 539–47. PMID: J Eval Clin Pract 2004; 10 (4): 539–47. 99. RКsКnen P, Erkonen K, Isaksson U et al. Delusional Parasitosis in the Elderly: A Review and Report of Six Cases From Northern Finland. International Psychogeriatrics 1997; 9 (4): 459–64. 100. Reilly TM, Batchelor DH. The presentation and treatment of delusional parasitosis: a dermatological perspective. Clin Pschiphannacol 1986; 1: 340–53. 101. Retterstol N. Paranoid psychoses with hypochondriac delusions as the main delusion. A personal follow-up investigation. Acta Psychiat Scand 1968; 44: 334–53. 102. Rief W, Buhlmann U, Wilhelm S et al. The prevalence of body dysmorphic disorder: a population-based survey. Psychol Med 2006; 36 (6): 877–85. 103. Robles DT, Romm S, Combs H et al. Delusional disorders in dermatology: a brief review. Dermatol Online J 2008; 14 (6): 2. 104. Rosen JC, Reiter J. Development of the body dysmorphic disorder examination. Behav Res Ther 1996; 34 (9): 755–66. 105. Sarwer DB, Wadden TA, Pertschuk MJ et al. Body image dissatisfaction and body dysmorphic disorder in 100 cosmetic surgery patients. Plastic Reconstruct Surg 1998; 101: 1644–9. 106. Savely VR, Leitao MM, Stricker RB. The mystery of Morgellons disease: infection or delusion? Am J Clin Dermatol 2006; 7 (1): 1–5. 107. Skott A. Delusion of infectation dermatozoenwahn Ekbonis syndrome. Reports from the Psychiatric Research Center 13. Gothenburg: University of Gothenburg, 1978. 108. Slaughter J, Zanol K, Rezvani H, Flax J. Psychogenic Parasitosis: A Case Series and Literature Review. Psychosomatics 1998; 39 (6): 491–500. 109. Srinivasan TN, Suresh TR, Vasantha J et al. Nature and treatment of delusional parasitosis: a different experience in India. Internat J Dermatol 1994; 33: 851–5. 110. Szepietowski JC, Salomon J, Hrehor?w E et al. Delusional parasitosis in dermatological practice. J Eur Acad Dermatol Venereol 2007; 21 (4): 462–5. 111. Taqui AM, Shaikh M, Gowani Saqib A et al. Body Dysmorphic Disorder: Gender differences and prevalence in a Pakistani medical student population. BMC Psychiat 2008; 8: 20. 112. Trabert W. 100 years of delusional parasitosis. Meta-analysis of 1,223 case reports. Psychopathol 1995; 28 (5): 238–46. 113. Uzun O, Ba?o?lu C, Akar A et al. Body dysmorphic disorder in patients with acne. Compr Psychiat 2003; 44 (5): 415–9. 114. Van Vloten W. Pimozide: Use in Dermatology. Dermatol Online J 2003; 9 (2). 115. Veale D. Cognitive–behavioural therapy for body dysmorphic disorder. Advan Psychiat Tretment 2001; 7: 125–32. 116. Veale D, Boocock A, Gournay K et al. Body dysmorphic disorder. A survey of fifty cases. Br J Psychiat 1996; 169 (2): 196–201. 117. Vinkers DJ, van Rood YR, van der Wee NJ. Prevalence and comorbidity of body dysmorphic disorder in psychiatric outpatients. Tijdschr Psychiatr 2008; 50 (9): 559–65. 118. Vulink NC, Rosenberg A, Plooij JM et al. Body dysmorphic disorder screening in maxillofacial outpatients presenting for orthognathic surgery. Int J Oral Maxillofac Surg 2008; 37 (11): 985–91. 119. Vulink NC, Sigurdsson V, Kon M et al. Body dysmorphic disorder in 3-8% of patients in outpatient dermatology and plastic surgery clinics. Ned Tijdschr Geneeskd 2006; 150 (2): 97–100. 120. Wenning M, Davy L, Catalano G, Catalano M. Atypical antipsychotics in the treatment of delusional parasitosis. Ann Clin Psychiat 2003; 15: 233–9. 121. Wykoff RF. Delusions of parasitosis: a review. Rev Infect Disord 1987; 9: 433–7. 122. Yorston G. Treatment of delusional parasitosis with sertindole (letter). Int J Geriatr Psychiat 1997; 12: 1127–8. 123. Zaidens SH. Dermatologic hypochondriasis a form of schizophrenia. Psychosom Med 1950; 12: 250–3. 124. Zomer S, De Fit R, Van Bronswijk J et al. Delusions of parasitosis. A psychiatric disorder to be treated by dermatologists? An analysis of 33 patients. Rev Infet Dis 1998; 138: 1030–2.